Search for: "Sanofi-Synthelabo v. Apotex Inc."
Results 21 - 39
of 39
Sorted by Relevance
|
Sort by Date
17 Jun 2014, 6:15 pm
Sanofi-Synthelabo v. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013… [read post]
12 Dec 2014, 10:29 pm
" Sanofi-Synthelabo v. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
13 May 2009, 11:44 pm
Cir. 2008); see also Sanofi-Synthelabo v. [read post]
2 Sep 2010, 10:51 am
Sanofi-Synthelabo v. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
13 Oct 2011, 7:45 pm
" Ecolab, 569 F.3d at 1352 (quoting Sanofi-Synthelabo v. [read post]
24 Sep 2010, 1:15 pm
Sanofi-Synthelabo v. [read post]
24 Aug 2011, 9:00 pm
Sanofi-Synthelabo v. [read post]
29 Oct 2009, 11:11 am
Sanofi-Synthelabo, Inc. [read post]
30 Nov 2009, 12:00 am
Budejovicky Budvar Narodni Podnik v Anheuser-Busch Inc (Class 46) (IPKat) EPO: Should green technology be subject to compulsory licensing? [read post]
7 Sep 2010, 8:52 am
Apotex, Inc., 550 F.3d 1075 (Fed. [read post]
20 Dec 2008, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oleg Teterin seeks ‘tens of thousands of dollars’ for rights to use ;-) emoticon, a registered Russian trade mark (Techdirt) (RelatIP) (Ars Technica) (The IP Factor) (Out-Law) (Class 46) New UK copyright consultation: consultation issues include access to works, incentivising investment and creativity, recognising… [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
24 Sep 2010, 1:06 pm
”Sanofi-Synthelabo v. [read post]
15 Feb 2011, 9:27 am
Michael Davitz, Partner at Axinn, Veltrop & Harkrider and Practice Center Contributor, recently sent in this article he wrote with colleague’s Drew Schulte and Jia Li discussing the Patent Prosecution Highway and the value that can be achieved for those practitioners willing to explore the new program. [read post]
10 May 2011, 1:29 pm
" Sanofi-Synthelabo v. [read post]
